Skip to content

Electromagnetic Stimulation for the Treatment of Urge Urinary Incontinence and Overactive Bladder

Electrical Field Stimulation for the Treatment of Urge Urinary Incontinence and Overactive Bladder - Version: 3.0 Dated 16 APR 2012.

Status
Terminated
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01464372
Acronym
ELEC STIM
Enrollment
130
Registered
2011-11-03
Start date
2011-10-31
Completion date
2013-01-31
Last updated
2013-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Incontinence, Urge

Keywords

Urinary Incontinence, Urge, Peripheral Nerve Stimulation

Brief summary

The purpose of this study is to collect data on the safety and efficacy of using an electrical field stimulation device, compared to a sham (placebo) device, to treat urinary urgency, urinary frequency and urge incontinence.

Interventions

DEVICEElectrical Field Stimulation Device

Treatment with Electrical Field Stimulation Device

DEVICESham Nerve Stimulation Device

Use of the sham device

Sponsors

EMKinetics, Inc
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Urinary Urge Incontinence * Urinary Frequency

Exclusion criteria

* Primary complaint of Stress Incontinence * Neurogenic bladder * Overflow Incontinence * Functional Incontinence

Design outcomes

Primary

MeasureTime frameDescription
Reduction of incontinence episodes from baseline to follow-up greater for device arm than sham armOne week after final treatment visitSignificant increase in the percentage of patients reporting a reduction in number of incontinence episodes per day for the investigational device vs. sham
No Serious Adverse Events or Unanticipated Adverse Device EffectsFirst treatment through follow-up (one week after last treatment)Freedom from Serious Adverse Events or Unanticipated Adverse Device Effects related to procedure and/or investigational device through follow-up

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026